Osaka, Japan-based Takeda Pharmaceutical and Los Altos, Calif.-based Altos Therapeutics are teaming up to develop Altos' proprietary compound to treat gastroparesis, according to Yahoo! Finance.
Here are five takeaways:
1. As part of the partnership, Takeda has the option to acquire Altos beginning on the agreement date and lasting until the completion of Altos' proprietary compound's Phase 1 clinical trials.
2. Altos is developing the proprietary compound to treat nausea and vomiting symptoms related to gastroparesis.
3. Other gastroparesis symptoms include early satiety, post-prandial fullness and abdominal discomfort.
4. Takeda is the largest pharmaceutical company in Japan.
5. Takeda has been involved in the gastroenterology field for more than 25 years.